
|Videos|October 24, 2017
Dr. Armstrong Discusses AR-V7 Testing in Prostate Cancer
Author(s)Andrew J. Armstrong, MD
Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses AR-V7 testing in prostate cancer.
Advertisement
Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses AR-V7 testing in prostate cancer.
Currently, there are 2 lead candidates for the AR-V7 test—the Epic Sciences AR-V7 Test from Genomic Health, and a Johns Hopkins assay that is based on RNA.
Neither of these studies are FDA approved, but both are undergoing prospective validation.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
4
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
5



































